James L. Tyree, Director at ChemoCentryx, Inc. (CCXI), sold 56,934 shares at $35.50 ($2.0M) on 2021-12-17, disclosed to the SEC on 2021-12-21.
Open-market sale of $2.0M CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.52 | 2,800 | $94K | 4.7% |
| 2 | $33.52 | 2,800 | $94K | 4.7% |
| 3 | $34.74 | 16,634 | $578K | 29.1% |
| 4 | $34.74 | 16,634 | $578K | 29.1% |
| 5 | $35.50 | 18,066 | $641K | 32.3% |
| Total | $34.86 avg | 56,934 |
| $2.0M |
| 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |